139 related articles for article (PubMed ID: 12131950)
1. Iatrogenic Creutzfeldt-Jakob disease following human growth hormone therapy: case report.
Caboclo LO; Huang N; Lepski GA; Livramento JA; Buchpiguel CA; Porto CS; Nitrini R
Arq Neuropsiquiatr; 2002 Jun; 60(2-B):458-61. PubMed ID: 12131950
[TBL] [Abstract][Full Text] [Related]
2. Creutzfeldt-Jakob disease 38 years after diagnostic use of human growth hormone.
Croes EA; Roks G; Jansen GH; Nijssen PC; van Duijn CM
J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):792-3. PubMed ID: 12023427
[TBL] [Abstract][Full Text] [Related]
3. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging.
Lewis AM; Yu M; DeArmond SJ; Dillon WP; Miller BL; Geschwind MD
Arch Neurol; 2006 Feb; 63(2):288-90. PubMed ID: 16476821
[TBL] [Abstract][Full Text] [Related]
4. [Cerebral magnetic resonance imaging in iatrogenic Creutzfeldt-Jacob disease].
Gurau C; Zeghoudi AC; Atlaoui-Rabia S; Charitanski D; Mallecourt J
Presse Med; 2005 Sep; 34(15):1080-1. PubMed ID: 16334885
[TBL] [Abstract][Full Text] [Related]
5. Increased detection of 14-3-3 protein in cerebrospinal fluid in Sporadic Creutzfeldt-Jakob Disease during the disease course.
Giraud P; Biacabe AG; Chazot G; Later R; Joyeux O; Moene Y; Perret-Liaudet A
Eur Neurol; 2002; 48(4):218-21. PubMed ID: 12422071
[TBL] [Abstract][Full Text] [Related]
6. Autopsy-proven Creutzfeldt-Jakob disease in a patient with a negative 14-3-3 assay and nonspecific EEG and MRI.
Donahue JE; Hanna PA; Hariharan S
Neurol Sci; 2004 Feb; 24(6):411-3. PubMed ID: 14767688
[TBL] [Abstract][Full Text] [Related]
7. Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: a new American case.
Marzewski DJ; Towfighi J; Harrington MG; Merril CR; Brown P
Neurology; 1988 Jul; 38(7):1131-3. PubMed ID: 3290703
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MRI in Creutzfeldt-Jakob disease: a better diagnostic marker than CSF protein 14-3-3?
Mendez OE; Shang J; Jungreis CA; Kaufer DI
J Neuroimaging; 2003 Apr; 13(2):147-51. PubMed ID: 12722497
[TBL] [Abstract][Full Text] [Related]
9. The Heidenhain variant of Creutzfeldt-Jakob disease: clinical, pathologic, and neuroimaging findings.
Jacobs DA; Lesser RL; Mourelatos Z; Galetta SL; Balcer LJ
J Neuroophthalmol; 2001 Jun; 21(2):99-102. PubMed ID: 11450911
[TBL] [Abstract][Full Text] [Related]
10. Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease.
Green AJ
Biochem Soc Trans; 2002 Aug; 30(4):382-6. PubMed ID: 12196099
[TBL] [Abstract][Full Text] [Related]
11. A case of Creutzfeldt-Jakob disease following cataract surgery: sporadic versus iatrogenic cause.
Gnanajothy R; Umashanker D; Vega MC; Wu BJ
Conn Med; 2013; 77(6):335-7. PubMed ID: 23923250
[TBL] [Abstract][Full Text] [Related]
12. [Iatrogenic Creutzfeld-Jakob disease. Significance of cases observed after extracted growth hormone treatment].
Billette de Villemeur T
Rev Neurol (Paris); 1998 Oct; 154(10):651-2. PubMed ID: 9846334
[No Abstract] [Full Text] [Related]
13. Creutzfeldt-Jakob disease risk in Slovak recipients of human pituitary growth hormone.
Mitrova E; Belay G
Bratisl Lek Listy; 1999 Apr; 100(4):187-91. PubMed ID: 10914140
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease.
Aksamit AJ; Preissner CM; Homburger HA
Neurology; 2001 Aug; 57(4):728-30. PubMed ID: 11524493
[TBL] [Abstract][Full Text] [Related]
15. Abnormal proteins in the cerebrospinal fluid of a patient with Creutzfeldt-Jakob disease following administration of human pituitary growth hormone.
Macário ME; Moura-Neto V; Vaisman M; Araujo HM; Buescu A; Cordeiro JG; Chagas C
Braz J Med Biol Res; 1992; 25(11):1127-30. PubMed ID: 1342593
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
Van Everbroeck B; Boons J; Cras P
Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
[TBL] [Abstract][Full Text] [Related]
17. Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Wiltfang J; Otto M; Baxter HC; Bodemer M; Steinacker P; Bahn E; Zerr I; Kornhuber J; Kretzschmar HA; Poser S; Rüther E; Aitken A
J Neurochem; 1999 Dec; 73(6):2485-90. PubMed ID: 10582609
[TBL] [Abstract][Full Text] [Related]
18. Determination of 14-3-3 protein levels in cerebrospinal fluid from Creutzfeldt-Jakob patients by a highly sensitive capture assay.
Peoc'h K; Schröder HC; Laplanche J; Ramljak S; Müller WE
Neurosci Lett; 2001 Apr; 301(3):167-70. PubMed ID: 11257424
[TBL] [Abstract][Full Text] [Related]
19. [Creutzfeldt-Jakob disease with unilateral onset: clinical profile and neuroimaging].
Blasco Olcina R; Yaya Huamán R; Garcés Sánchez M; Villanueva Haba VE; Bataller Alberola L; Baquero Toledo M
Neurologia; 2001 Oct; 16(8):381-4. PubMed ID: 11738017
[TBL] [Abstract][Full Text] [Related]
20. [Creutzfeldt-Jakob disease: diagnostic value of protein 14-3-3 and neuronal specific enolase assay in cerebrospinal fluid].
Brandel JP; Beaudry P; Delasnerie-Lauprêtre N; Laplanche JL
Rev Neurol (Paris); 1999 Feb; 155(2):148-51. PubMed ID: 10226319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
